1. Home
  2. GTBP vs JCSE Comparison

GTBP vs JCSE Comparison

Compare GTBP & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • JCSE
  • Stock Information
  • Founded
  • GTBP 1965
  • JCSE 1999
  • Country
  • GTBP United States
  • JCSE Singapore
  • Employees
  • GTBP N/A
  • JCSE N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • GTBP Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • GTBP Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • GTBP 6.8M
  • JCSE 7.6M
  • IPO Year
  • GTBP N/A
  • JCSE 2022
  • Fundamental
  • Price
  • GTBP $2.39
  • JCSE $1.47
  • Analyst Decision
  • GTBP Strong Buy
  • JCSE
  • Analyst Count
  • GTBP 1
  • JCSE 0
  • Target Price
  • GTBP $11.00
  • JCSE N/A
  • AVG Volume (30 Days)
  • GTBP 1.3M
  • JCSE 35.1K
  • Earning Date
  • GTBP 11-14-2024
  • JCSE 10-30-2024
  • Dividend Yield
  • GTBP N/A
  • JCSE 12.29%
  • EPS Growth
  • GTBP N/A
  • JCSE N/A
  • EPS
  • GTBP N/A
  • JCSE 0.12
  • Revenue
  • GTBP N/A
  • JCSE $14,723,999.00
  • Revenue This Year
  • GTBP N/A
  • JCSE N/A
  • Revenue Next Year
  • GTBP N/A
  • JCSE N/A
  • P/E Ratio
  • GTBP N/A
  • JCSE $11.87
  • Revenue Growth
  • GTBP N/A
  • JCSE N/A
  • 52 Week Low
  • GTBP $1.72
  • JCSE $0.60
  • 52 Week High
  • GTBP $10.66
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 42.95
  • JCSE 51.62
  • Support Level
  • GTBP $2.32
  • JCSE $1.37
  • Resistance Level
  • GTBP $2.63
  • JCSE $1.48
  • Average True Range (ATR)
  • GTBP 0.27
  • JCSE 0.11
  • MACD
  • GTBP -0.05
  • JCSE -0.00
  • Stochastic Oscillator
  • GTBP 33.00
  • JCSE 47.14

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

Share on Social Networks: